1. A tablet comprising at least a first and a second active component, wherein the first active component is in the form of a non-aqueous granulate and the second active ingredient is in the form of granules or granules (aqueous or non-aqueous) obtained by melt extrusion, wherein said first and the second active components are mixed together, optionally with other excipients, and formed into a tablet. 2. The tablet according to claim 1, wherein the first active ingredient is selected from antihistamines, sympathomimetics (decongestants), cough suppressants and expectorants selected from chlorpheniramine, brompheniramine, dexchlorpheniramine, dexbrompheniramine, triprolidine, diphenhydramine, doxylapinframine, trixepinfedamine, trixepinfedamine, trixepinamine, trixepinfedamine, trixepinfedamine, trixepinfedamine, trixepinamidamine, trixepinfedamine, trixepinamine, trihydramidine amine, trihydramidine amine , phenindamine, pyrilamine, azatadine, pseudoephedrine, phenylpropanolamine, phenylephrine, karamifen, dextromethorphan, codeine, terpinghydrate, guaifenesin. 3. A tablet according to claim 2, wherein the first active component is diphenylhydramine or a pharmaceutically acceptable salt thereof. Tablet according to any one of paragraphs. 1-3, where the second active component is selected from a suitable non-steroidal anti-inflammatory drug. A tablet according to claim 4, wherein the non-steroidal anti-inflammatory drug is selected from any of the following groups: a) derivatives of propionic acid； b) derivatives of acetic acid； c) derivatives of phenamic acid； d) derivatives of biphenylcarboxylic acid； f) oxicam. 6. A tablet according to claim 1, wherein phenylpropionic acid is an NSAID and is selected from ibuprofen, naproxen, ketoprofen and flurbiprofen. � tablet1. Таблетка, включающая по меньшей мере первый и второй активный компонент, где первый активный компонент представлен в форме неводного гранулята, а второй активный ингредиент представлен в форме гранул ил
